Cilnidipine exerts antiviral effects in vitro and in vivo by inhibiting the internalization and fusion of influenza A virus
These findings highlight the promising anti-IAV properties of cilnidipine both in vitro and in vivo, suggesting its potential as a clinical agent for emergencies against influenza outbreaks.
Authors
- Jie Yang (ORCID: https://orcid.org/0000-0003-1789-690X)
- Linrui Jiang
- Jinlong Liang
- Yinyan Li (ORCID: https://orcid.org/0000-0002-8470-291X)
- Xin Chen (ORCID: https://orcid.org/0000-0003-4426-2363)
- Feng Jiang (ORCID: https://orcid.org/0009-0005-7690-3403)
- Zhixuan Chen (ORCID: https://orcid.org/0000-0001-8767-7177)
- Sizu Yang
- Siqi Luo
Institutions
- Guangdong Pharmaceutical University (CN)
- Zhujiang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1186/s12916-025-04022-0
- Citations
- 9
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 12.19
Funders
- National Natural Science Foundation of China